Kerry Dooley Young

Senate bill requires Medicare to test AI tools to prevent fraud, along with quick customer notifications of suspicious activity. Medicare shouldn't ask patients to verify flagged claims, critics said.

Canada has postponed a legal change needed to permit medical assistance in dying in cases of mental illnesses.

Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.

Physician groups continue to press for major revamp Medicare payments after securing a 2024 stopgap fix.

While broadly welcomed, the launch of the first nonprescription birth control pill in the United States raises some concerns about patients' understanding of the dosing schedule and risks when taking the drug on their own.

An FDA advisory panel endorsed earlier use of CAR-T therapies to treat multiple myeloma but emphasized the importance of informing patients about potential risks associated with these treatments.

Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger debate about using genetic information to guide clinical care.

A new report on trends in medical practice ownership came amid increased federal scrutiny of consolidation and the role of private equity.

ODAC unanimously backed the use of highly sensitive tests that check for minimal residual disease to speed up drug approvals for multiple myeloma.

The USPSTF has shifted to a stronger recommendation to start mammograms earlier, noting a need for more research on breast cancer for Black and older women and those with dense breasts.